InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,348.40
(
0.44%
)
Dow Jones
39,164.06
(
0.00%
)
Brent Oil
85.56
(
0.16%
)
Bitcoin
61,573.40
(
-0.06%
)
Post# of 426270
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

heysfguy

Send PM Follow Ignore
Followers 3
Posts 190
Boards Moderated 0
Alias Born 05/16/2013

heysfguy

Re: Whalatane post# 194660

Saturday, 06/01/2019 11:08:41 PM

Saturday, June 01, 2019 11:08:41 PM

Post# of 426270
What, you make point I have also been pondering. With Alzheimer studies ahead, not to mention EVAPORATE due later this year, why would AMRN feel it necessary to tackle EU approvals or even buyout at this point? I personally get the feeling they have been stalling on certain rollout options specifically to wait for results from EVAPORATE.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!